Epistaxis Nosebleed
8
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block
Treatment of Nosebleeds in the Emergency Department With Powder Tranexamic Acid
Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
Coblation Versus Bipolar Diathermy in Management of Refractory Idiopathic Recurrent Anterior Epistaxis in Children.
Atmospheric Pressure and Epistaxis Relationship
Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management
Nasal Compression Device Study for Epistaxis
Guidewire Use in Nasotracheal Intubation